Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Canella

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
European Journal of Pharmacology|October 1, 2011
C(5) modified uracil derivatives showing antiproliferative and erythroid differentiation inducing activities on human chronic myelogenous leukemia K562 cellsEleonora Brognara, Ilaria Lampronti, Giulia Breveglieri, et al.
European Journal of Immunology|January 5, 2002
Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individualsSimona Vertuani, Martina Bazzaro, Guido Gualandi, et al.
Molecular Therapy. Oncology|March 2, 2026
Trabectedin decreases myeloid resistance to improve the efficacy of anti-PD1 immunotherapy and delay glioma malignant progressionMatthew Nazzaro, Elaine R Mardis, Alessandro Canella, et al.
Biotechnology and Applied Biochemistry|February 17, 2009
Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassaemia mutation for the screening of correctors of stop-codon mutationsFrancesca Salvatori, Vera Cantale, Giulia Breveglieri, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2004
HIV-1 tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activityRiccardo Gavioli, Eleonora Gallerani, Cinzia Fortini, et al.
Bioorganic & Medicinal Chemistry Letters|March 3, 2009
Hybrid alpha-bromoacryloylamido chalcones. Design, synthesis and biological evaluationRomeo Romagnoli, Pier Giovanni Baraldi, Maria Dora Carrion, et al.
American Journal of Hematology|October 8, 2009
Production of beta-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous beta(0)39 thalassemia patientsFrancesca Salvatori, Giulia Breveglieri, Cristina Zuccato, et al.
Cells|January 22, 2021
Unlike Its Paralog LEDGF/p75, HRP-2 Is Dispensable for MLL-R Leukemogenesis but Important for Leukemic Cell SurvivalSiska Van Belle, Sara El Ashkar, Kateřina Čermáková, et al.
Molecular Therapy. Oncology|May 24, 2024
BRAF V600E in a preclinical model of pleomorphic Xanthoastrocytoma: Analysis of the tumor microenvironment and immune cell infiltration dynamics <i>in vivo</i>Alessandro Canella, Matthew Nazzaro, Mykyta Artomov, et al.
Cell Reports|July 30, 2023
Genetically modified IL2 bone-marrow-derived myeloid cells reprogram the glioma immunosuppressive tumor microenvironmentAlessandro Canella, Matthew Nazzaro, Sakthi Rajendran, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
European Journal of Pharmacology|October 1, 2011
C(5) modified uracil derivatives showing antiproliferative and erythroid differentiation inducing activities on human chronic myelogenous leukemia K562 cellsEleonora Brognara, Ilaria Lampronti, Giulia Breveglieri, et al.
European Journal of Immunology|January 5, 2002
Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individualsSimona Vertuani, Martina Bazzaro, Guido Gualandi, et al.
Molecular Therapy. Oncology|March 2, 2026
Trabectedin decreases myeloid resistance to improve the efficacy of anti-PD1 immunotherapy and delay glioma malignant progressionMatthew Nazzaro, Elaine R Mardis, Alessandro Canella, et al.
Biotechnology and Applied Biochemistry|February 17, 2009
Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassaemia mutation for the screening of correctors of stop-codon mutationsFrancesca Salvatori, Vera Cantale, Giulia Breveglieri, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2004
HIV-1 tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activityRiccardo Gavioli, Eleonora Gallerani, Cinzia Fortini, et al.
Bioorganic & Medicinal Chemistry Letters|March 3, 2009
Hybrid alpha-bromoacryloylamido chalcones. Design, synthesis and biological evaluationRomeo Romagnoli, Pier Giovanni Baraldi, Maria Dora Carrion, et al.
American Journal of Hematology|October 8, 2009
Production of beta-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous beta(0)39 thalassemia patientsFrancesca Salvatori, Giulia Breveglieri, Cristina Zuccato, et al.
Cells|January 22, 2021
Unlike Its Paralog LEDGF/p75, HRP-2 Is Dispensable for MLL-R Leukemogenesis but Important for Leukemic Cell SurvivalSiska Van Belle, Sara El Ashkar, Kateřina Čermáková, et al.
Molecular Therapy. Oncology|May 24, 2024
BRAF V600E in a preclinical model of pleomorphic Xanthoastrocytoma: Analysis of the tumor microenvironment and immune cell infiltration dynamics <i>in vivo</i>Alessandro Canella, Matthew Nazzaro, Mykyta Artomov, et al.
Cell Reports|July 30, 2023
Genetically modified IL2 bone-marrow-derived myeloid cells reprogram the glioma immunosuppressive tumor microenvironmentAlessandro Canella, Matthew Nazzaro, Sakthi Rajendran, et al.
Pageof 4